Olsalazine as an Alternative Therapy in a Patient with Sulfasalazine-Induced Eosinophilic Pneumonia

A man with Crohnʼs colitis developed eosinophilic pneumonia after treatment with sulfasalazine. Challenge with sulfapyridine revealed that this component of sulfasalazine was the likely causative agent. Treatment with olsalazine, a 5-aminosalicylic acid compound (disodium-azodisalicylate), was well...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical gastroenterology 1988-04, Vol.10 (2), p.218-220
Hauptverfasser:	Scherpenisse, J, van der Valk, P D. L. P. M, van den Bosch, J M. M, van Hees, P A. M, Nadorp, J H. S. M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aminosalicylic Acids - therapeutic use Biological and medical sciences Colitis - drug therapy Crohn Disease - drug therapy Digestive system Humans Male Medical sciences Pharmacology. Drug treatments Pulmonary Eosinophilia - chemically induced Sulfasalazine - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A man with Crohnʼs colitis developed eosinophilic pneumonia after treatment with sulfasalazine. Challenge with sulfapyridine revealed that this component of sulfasalazine was the likely causative agent. Treatment with olsalazine, a 5-aminosalicylic acid compound (disodium-azodisalicylate), was well tolerated without recurrence of pulmonary symptoms.
ISSN:	0192-0790 1539-2031
DOI:	10.1097/00004836-198804000-00024